Absci (ABSI) Stock Price

Absci Price

NASDAQ·CLOSED
10.27
​
Market closed

Revenue has compounded at 5.2% per year over the past 6 years to 2.80 M USD. Absci's net margin stands at -4,113.7%, down from -2,111.3% several years earlier. Analysts set a median price target of 12.00 USD, implying 16.8% above the current price. Of 16 analysts, 14 rate the stock a buy — an overall Buy consensus.

Absci stock price

Access this data via the Eulerpool API

Absci business model & stock analysis

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. The company is headquartered in Vancouver Washington, Washington and currently employs 193 full-time employees. The company went IPO on 2021-07-22. The firm combines AI with scalable wet lab technologies to create biologics for patients. The company has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The firm uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The firm supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. The firm applies generative AI to design optimal drug candidates based on target affinity, safety, manufacturability, and other traits.

Frequently asked questions about Absci

Analysts currently set an average price target of 12.40 USD for the Absci stock (median: 12.00 USD), implying +20.7 % versus the latest price. The consensus is based on 16 analyst ratings.

16 analysts currently rate the Absci stock: 14 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Absci to generate revenue of 3.89 M USD and earnings per share of -0.80 USD.

Converted at the current exchange rate, the Absci share trades at 9.17 EUR (10.27 USD).

The Absci share (ABSI) is listed on 1 stock exchanges, including: NASDAQ (ABSI).

The expected revenue of Absci is 3.89 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Absci is -120.10 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Absci is currently -12.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Absci stock.

The price-to-sales ratio (P/S) of Absci is currently 397.35. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Absci stock.

The Eulerpool Quality Score for Absci is 2/10.

The ISIN of Absci is US00091E1091. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Absci is ABSI. The ticker symbol is used to trade Absci shares on the stock exchange.

Fair ValueTerminal
9.65 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
20,000.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website absci.com
Currency
USD
Initial public offering
Jul 22, 2021
ISIN
US00091E1091
Cusip
00091E109
Market capitalization
1.54 B USDSmall Cap
52-Week Range
PEG
0.25
P/E ratio
P/Ee 2026
-12.88
P/Ee 2027
-14.22
P/Ee 2028
-17.89
P/Ee 2029
-23.51
P/Ee 2030
-587.80
P/Se
397.35
EV/EBIT
—
P/B Ratio
8.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-59.95 %
Last updated Oct 8, 2026, 1:44 AM

Absci Peer Group

Absci Ticker

NASDAQ · ABSI

Absci FIGI

ABSI:US · BBG011N54CJ8ABSI:UA · BBG011N54CK6ABSI:UC · BBG011N54CL5ABSI:UN · BBG011N54CN3ABSI:UP · BBG011N54CP1ABSI:UB · BBG011N54CR9ABSI:UM · BBG011N54CT7ABSI:UX · BBG011N54CV4ABSI:UD · BBG011N54D06ABSI:UW · BBG011N54D24ABSI:UF · BBG011N54D33ABSI:VY · BBG011N54D42

All fundamentals and in-depth analysis of Absci

Our stock analysis for Absci stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Absci. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.